Continuous prazosin administration in cirrhotic patients: Effects on portal hemodynamics and on liver and renal function

Gastroenterology

Volumn 109, Issue 4, 1995, Pages 1257-1265

  Albillos, Agustín ^a   Lledó, Jose Luis ^a   Rossi, Irma ^a   Pérez Páramo, María ^a   Tabuenca, Maria Jose ^a   Bañares, Rafael ^b   Iborra, Jerónimo ^a   Garrido, Aurelio ^a   Escartín, Pedro ^a   Bosch, Jaime ^c  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; PLACEBO; PRAZOSIN; PROPRANOLOL; RENIN;

ADULT; AGED; ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER PERFUSION; MALE; PLASMA RENIN ACTIVITY; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM RETENTION; WATER RETENTION;

EID: 0029088488     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(95)90586-3     Document Type: Article

References (36)

1. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators
2. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis
3. Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension
4. Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver
5. Chronic verapamil administration lowers portal pressure and improves hepatic function in rats with liver cirrhosis
6. Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis
7. Total and renal sympathetic nervous system activity in alcoholic cirrhosis
8. Hepatic intestinal uptake and release of catecholamines in alcoholic cirrhosis
9. Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings
10. Liver blood flow I. Intrinsic and nervous control of liver blood flow
11. Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis-plasma norepinephrine concentration, hepatic extraction, and renal release
12. Comparison of three adrenoceptor blocking agents in patients with cirrhosis and portal hypertension
13. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
14. Chronic oral clonidine administration in patients with alcoholic cirrhosis: hemodynamic and liver function effects
15. Determination of the hepatic elimination capacity (Lm) of galactose by single injection
16. Blood volume
17. Measurement of renal function with radioactive materials
18. Effects of propranolol on azygos venous blood and hepatic and systemic hemodynamics in cirrhosis
19. Short-term effects of propranolol on portal venous pressure
20. Renal effects of drugs used in the treatment of portal hypertension
21. Renal effects of acute 5-isosorbide-mononitrate administration in cirrhosis
22. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects
23. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension
24. Hepatic clearance and liver blood flow
25. A physiological approach to hepatic drug clearance
26. Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat
27. Augmentation of portal blood flow improves function of human cirrhotic liver
28. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis
29. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension
30. 51Cr] EDTA plasma clearance determination in patients with ascites
31. Effect of β-adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites
32. Reduction of portal pressure by acute administration of furosemide in patients with alcoholic cirrhosis
33. Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites
34. Hemodynamic effects of acute administration of furosemide in patients with cirrhosis receiving β-adrenergic antagonists
35. The effects of synthetic vasopressin and angiotensin on the circulation in cirrhosis of the liver
36. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis